Almac Sciences

Building upon the strong biocatalytic technology base already available at Almac, we have successfully applied this technology to oligonucleotide synthesis using Almac’s selectAZyme™ panels for production of both single stranded and double stranded products. Get in touch with us at biocatalysis@almacgroup.com to learn more. #oligonucleotide #oligos #biocatalysis #drugdevelopment

Would you like to discover how Almac Sciences' technology expertise can benefit your chemical development programmes? Our experts Tom Moody, Jonathan Loughrey and Megan Smyth will be in Japan next week delivering seminars covering: - Carbon-14 isotopic radiolabelling of peptides - Integration of continuous flow into early pipeline development - Biotransformations – enzyme discovery, screening and selection to process design and scale-up - Solubility-enhancing technologies for APIs - Biocatalytic convergent synthesis of RNA oligonucleotides Join us in Osaka on 3rd December or Tokyo on 5th December. Register your place now: https://hubs.li/Q02Zl5cQ0

Jill Saunders, Analytical Technical Leader in Almac Sciences, was recently invited to speak at Southern Regional College’s 10 year celebration event as an HLA Ambassador. Jill started her journey as a Higher Level Apprentice in Applied Industrial Sciences and went on to complete a BSc. (Hons) in Applied Pharmaceutical Sciences and a Master's in Pharmaceutical Analysis.   Discover career opportunities at Almac: https://hubs.li/Q02ZNYNh0  #HLA10Years #AlmacCareers #InspiringJourneys

Our Technology Team will join naoki miki in Japan next week at the Japanese Society for Process Chemistry Winter Meeting, taking place on 6th December in Shizuoka. Contact us today to arrange a meeting to learn more about how our innovative techniques can enhance your drug development programmes. sciences@almacgroup.com Tom Moody, Jonathan Loughrey, Megan Smyth #drugdevelopment #biocatalysis #physicalsciences #radiolabelling #flowchemistry

Analytical Quality by Design (AQbD) is a science and risk-based approach to analytical procedure development that “starts with the end in mind”. jerome pretre and James Sweatman will be participating in Waters Corporation's AQbD Symposium webinar to discuss AQbD within the lab environment and pharmaceutical analytical development strategies. Register your free place here: https://hubs.li/Q02ZMRn50

We are excited to participate at the Winter Process Chemistry Conference next month in Birmingham! Get in touch to arrange a meeting with Geoff Porritt or to learn more about Darren Conboy's presentation, "Development and Scale-Up of 7-COOH CBD Synthesis, a Key Cannabinoid Metabolite" and our expertise in this area. https://hubs.li/Q02ZJjff0 #winterprocesschemistry #drugdevelopent

Happy Thanksgiving from the Almac Group! We are grateful for our people, our partners, and our customers. Have a wonderful holiday season! Pictured: Colleagues in Souderton, PA giving back during our "Month of Volunteering" this year in the US.

We are live at #BOS in Manchester this week! It's not too late to get in touch and arrange a meeting with our team, or stop by the Almac stand to learn why you should Think Almac for API development outsourcing. https://hubs.li/Q02Zwdzp0 #BOSManchester24 Geoff Porritt, Anna Cousens, Jonathan Loughrey

Would you like to discover how Almac Sciences' technology expertise can benefit your chemical development programmes? Our experts Tom Moody, Jonathan Loughrey and Megan Smyth will be in Japan next week delivering seminars covering: - Carbon-14 isotopic radiolabelling of peptides - Integration of continuous flow into early pipeline development - Biotransformations – enzyme discovery, screening and selection to process design and scale-up - Solubility-enhancing technologies for APIs - Biocatalytic convergent synthesis of RNA oligonucleotides Join us in Osaka on 3rd December or Tokyo on 5th December. Register your place now: https://hubs.li/Q02Zl4Fn0

Developing a #radiopharmaceutical agent for imaging and therapy is a complex and challenging endeavour. At Almac, we offer comprehensive support throughout the journey from early development to commercial launch. Connect with Alaric Desmarchelier at the Targeted Radiopharmaceuticals Summit in Amsterdam next month to learn how our expertise can enhance your radiopharmaceutical development programme. Get in touch: peptides@almacgroup.com